Amgenbd.com

Amgenbd.com has Server used 52.41.64.84 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2014-06-10 (6 years, 312 days) and hosted in Boardman United States, server ping response time 117 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Amgenbd keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Amgen bd
2 Amgen bd internship
3 Amgen devices
4 Amgen dividend 2021
5 Amgen dividend
6 Amgen dai
7 Amgen dc
8 Amgen dtc
9 Amgen dll3

Hosting Provider

Website: Amgenbd.com
Hostname: ec2-52-41-64-84.us-west-2.compute.amazonaws.com
Country:
Region: OR
City: Boardman
Postal Code: 97818
Latitude: 45.869598388672
Longitude: -119.68800354004
Area Code: 541
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Amgenbd.com (0 seconds ago)

   » Cvillefreeclinic.org (28 seconds ago)

   » Goshencountychamber.com (19 seconds ago)

   » Stepcentral.org (1 seconds ago)

   » Schroederhall.com (10 seconds ago)

   » Pcimagcn.com (21 seconds ago)

   » Izumiya-office.com (14 seconds ago)

   » Tennantcapital.com (1 seconds ago)

   » Valleydental.com (30 seconds ago)

   » Trekhp.com (8 seconds ago)

Results For Websites Listing

Found 46 Websites with content related to this domain, It is result after search with search engine

Amgen Business Development VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 70

  • Website: https://www.amgenbd.com/ The firm is a venture capital arm of Amgen Inc
  • specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies.

How Amgen Makes Money

Revenuesandprofits.com   DA: 22 PA: 50 MOZ Rank: 73

  • a biotechnology pioneer, is one of the world’s leading independent biotechnology companies
  • The company uses human genetics and advanced biotechnology tools to discover, develop, manufacture and sell innovative human therapeutics. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987.

Kymera Therapeutics Announces Series A To Advance Novel

Kymeratx.com   DA: 16 PA: 50 MOZ Rank: 68

  • The company is pioneering a novel targeted protein degradation platform and approach to accelerate drug discovery and development, and deliver on its mission
  • The round was led by Atlas Venture, which co-founded, seeded, and incubated the company, along with Lilly Ventures and Amgen

GPB Scientific Announces $25.5 Million Financing From

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 71

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures Financing to drive development and commercialization of innovative cell & gene therapy processing solution

Kymera Therapeutics Announces Series A To Advance Novel

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 72

The round was led by Atlas Venture, which co-founded, seeded, and incubated the company, along with Lilly Ventures and Amgen Ventures.

Drug Discovery Investors Drug Hunter

Drughunter.com   DA: 14 PA: 26 MOZ Rank: 45

  • Drug Discovery Investors Drug Discovery Companies | Drug Discovery Investors | Drug Discovery IPOs This page lists investment firms that specialize in making significant investments in drug discovery companies (or specialize in the life sciences with previous successful investments in drug discovery R&D companies)
  • This list doesn’t include all of […]

190325 Amgen Ventures Catalog Sheet 8.5x11in

Wwwext.amgen.com   DA: 16 PA: 50 MOZ Rank: 72

Therapeutics and Drug Discovery Platforms Ventures Focused Areas of Interest Investment Framework About Us Working With Amgen Ventures Amgen, the parent company of Amgen Ventures, has always appreciated the importance of funding

BioPharma Corporate Venture Capital Investment Trends

Lqventures.com   DA: 18 PA: 50 MOZ Rank: 75

  • When you visit any website, it may store or retrieve information on your browser in the form of cookies
  • Since we respect your right to privacy, you can choose not to permit data collection from certain types of services.

NAVAN Closes Seed Funding Round

Navanbio.com   DA: 16 PA: 44 MOZ Rank: 68

  • Investors include Amgen Ventures, HTGF and Hemi Ventures
  • SOUTH SAN FRANCISCO, Calif., April 25, 2019 – NAVAN Technologies, Inc
  • (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced it had closed a seed investment round led by Amgen Ventures, High …

Provention Bio (PRVB)

Thebiotechinvestor.freeforums.net   DA: 33 PA: 50 MOZ Rank: 92

  • I now thought weeks about this company and i would like to discuss this with you
  • PRVB was founded just 4 Years ago in 2016

Amgen Ventures Investment Information CipherBio

Cipherbio.com   DA: 17 PA: 35 MOZ Rank: 62

  • Taking a Look at Q4 2020 Accelerators and Incubators Funding Insights 3/9/21
  • The fourth quarter of 2020 remained a challenging time for the economy worldwide, but global markets got a dose of optimism as several companies introduced vaccines for COVID-19.

Kymera Therapeutics Announces Series A To Advance Novel

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 88

  • 30, 2017 /PRNewswire/ -- Kymera Therapeutics LLC today announced a $30M Series A Financing round to advance a transformatio

GPB Scientific Announces $25.5 Million Financing From

Biospace.com   DA: 16 PA: 50 MOZ Rank: 78

  • Financing to drive development and commercialization of innovative cell & gene therapy processing solution
  • and RICHMOND, Va., April 2, 2020 /PRNewswire/ -- GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment
  • The financing is led by Vensana Capital alongside …

GPB Scientific Announces $25.5 Million Financing From

Apnews.com   DA: 10 PA: 47 MOZ Rank: 70

  • About GBP Scientific GPB Scientific is a pioneering biomedical company working with leading research institutes and universities to develop breakthrough technologies to get people better
  • GPB Scientific’s Curate™ Cell Processing System applies microfluidic deterministic lateral displacement in advanced biocompatible cartridges and an easy to use robust, closed fluid path instrumentation

Partnering With Innovators To Treat Serious Illness

Doczz.net   DA: 9 PA: 50 MOZ Rank: 73

  • For more information visit www.amgenbd.com Amgen’s Business Development Team Dave Piacquad Senior Vice President Business Development [email protected] William Erb Vice President Business Development [email protected] Bethany Mancilla Vice President Business Development [email protected] Ray Barlow, Ph.D
  • Executive Director Transactions

Similar Companies To Amgen VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 85

  • Amgen Business Development. n/a
  • The firm is a venture capital arm of Amgen Inc
  • specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies.

NAVAN Closes Seed Funding Round

Htgf.de   DA: 11 PA: 50 MOZ Rank: 77

  • (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced it had closed a seed investment round led by Amgen Ventures, High-Tech Gründerfonds (HTGF), Hemi Ventures, and other institutional and private investors.

LifeArc Co-leads £6 Million Funding In DJS Antibodies

Lifearc.org   DA: 15 PA: 50 MOZ Rank: 82

  • For more information, please visit www.amgenbd.com
  • LifeArc appoints Dr Linda Bradley to head up business development
  • Dr Linda Bradley has joined as our new Head of Business Development, effective immediately

GPB Scientific Announces $25.5 Million Financing From

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 85

  • GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment

Amgenhistory.com Competitive Analysis, Marketing Mix And

Alexa.com   DA: 13 PA: 26 MOZ Rank: 58

What marketing strategies does Amgenhistory use? Get traffic statistics, SEO keyword opportunities, audience insights, and competitive analytics for Amgenhistory.

Kymera Therapeutics Announces $30M Series A

Vcnewsdaily.com   DA: 19 PA: 50 MOZ Rank: 89

  • For more information, please visit www.amgenbd.com
  • About Lilly Ventures Since 2002, Lilly Ventures has sought to invest in great companies with compelling life science innovations that have the potential to create a pipeline of life-changing medicines
  • We partner actively with our portfolio company management teams and provide intellectual, as

Crowdsourcing And Open Innovation In Drug Discovery

Sciencedirect.com   DA: 21 PA: 38 MOZ Rank: 80

  • The ecosystem required to cultivate the discovery, development, distribution, and marketing of novel chemical material is a complex-adaptive system
  • 2018 saw a record number of new drug approvals from US regulators, exceeding the previous record of 50 set in 1996 , while 48 new drugs were approved in 2019.It is too soon, and too complex an environment, to distinctly attribute

LifeArc Co-leads £6 Million Funding In DJS Antibodies

Stevenagecatalyst.com   DA: 25 PA: 50 MOZ Rank: 97

LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the development of novel antibody therapeutics for inflammatory disease.LifeArc is co-leading the c.£6 million funding with Sedgwick Yard, with new investment from Amgen Ventures and follow-on investment from Oxford Sciences Innovation (OSI).

GPB Scientific Announces $25.5 Million Financing From

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 85

  • and RICHMOND, Va., April 2, 2020 /PRNewswire/ -- GPB Scientific, Inc., a developer of breakthrough technologies for therapeutic cell production and bioprocessing, today announced a $25.5 million funding commitment
  • The financing is led by Vensana Capital alongside strategic investor Amgen Ventures with ongoing participation by existing investors.

BIA LifeArc Co-leads £6 Million Funding In DJS Antibodies

Bioindustry.org   DA: 19 PA: 50 MOZ Rank: 93

  • For more information, please visit www.amgenbd.com
  • 13 Apr 21 Member News HotHouse BioEngineering and Leaf Expression Systems Sign Plant-Based Expression License Agreement
  • 13 Apr 21 Member News R&D Tax Credits – The three most common areas life sciences companies underclaim

GPB Scientific Secures $25.5M

Vcnewsdaily.com   DA: 15 PA: 50 MOZ Rank: 90

  • The financing is led by Vensana Capital alongside strategic investor Amgen Ventures with ongoing participation by existing investors
  • GPB Scientific previewed its Curate™ Cell Processing System in January at the Phacilitate World Leaders / Stem Cell Summit, where it attracted high interest for its exceptional performance.

Janis Naeve — WOMEN VC

Women.vc   DA: 8 PA: 26 MOZ Rank: 60

  • Tudor is a collective of bloggers that explores design in many forms – from interior design and architecture, to the culinary and decorative arts.

Citybizlist : Boston : Kymera Therapeutics Raises $30M In

Boston.citybizlist.com   DA: 22 PA: 50 MOZ Rank: 99

  • For more information, please visit www.amgenbd.com
  • Since 2002, Lilly Ventures has sought to invest in great companies with compelling life science innovations that have the potential to create a pipeline of life-changing medicines
  • We partner actively with our portfolio company management teams and provide intellectual

Decode.com Competitive Analysis, Marketing Mix And Traffic

Alexa.com   DA: 13 PA: 20 MOZ Rank: 61

  • amgenbd.com decode.is decoded.com decodeproject.eu
  • Find, Reach, and Convert Your Audience
  • Get free, customized ideas to outsmart competitors and take your search marketing results to the next level with Alexa's Site Overview tool
  • Discover even more ideas with a free trial of Alexa's Advanced Plan

NAVAN Closes Seed Funding Round BioSpace

Biospace.com   DA: 16 PA: 50 MOZ Rank: 95

  • SOUTH SAN FRANCISCO, Calif., April 25, 2019 /PRNewswire/ -- NAVAN Technologies, Inc
  • (NAVAN), a privately-held biotechnology company enabling the development of next generation cell and gene therapies through its novel, non-viral NanoStraw platform, announced it had closed a seed investment round led by Amgen Ventures, High-Tech Gründerfonds (HTGF), Hemi Ventures, and …

Recently Analyzed Sites

Amgenbd.com (1 seconds ago)

Cvillefreeclinic.org (29 seconds ago)

Goshencountychamber.com (20 seconds ago)

Stepcentral.org (2 seconds ago)

Schroederhall.com (11 seconds ago)

Awzan.net (0 seconds ago)

Izumiya-office.com (15 seconds ago)

Tennantcapital.com (2 seconds ago)

Valleydental.com (31 seconds ago)

Trekhp.com (9 seconds ago)

Cjwconstruction.com (8 seconds ago)

Pcthreat.com (41 seconds ago)

Waynesflooringoutlet.com (4 seconds ago)

Authenticsportsgems.com (4 seconds ago)

Idigtv.net (9 seconds ago)

Roostsolar.com (4 seconds ago)

Glenwoodlibrary.com (4 seconds ago)